PROBODY

Serial Number 86711505
606

Registration Progress

Application Filed
Jul 31, 2015
Under Examination
Apr 19, 2016
Approved for Publication
Feb 23, 2016
Published for Opposition
Feb 23, 2016
Registered

Trademark Image

PROBODY

Basic Information

Serial Number
86711505
Filing Date
July 31, 2015
Published for Opposition
February 23, 2016
Abandonment Date
May 20, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 20, 2019
Classes
042

Rights Holder

CytomX Therapeutics, Inc.

03
Address
151 Oyster Point Blvd, Suite 400
South San Francisco, CA 94080

Ownership History

CytomX Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

CytomX Therapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Janet L. Cullum

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description Documents
May 20, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 20, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 19, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 18, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 16, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 16, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 20, 2018 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 12, 2018 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Apr 20, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 18, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 18, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 18, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 3, 2017 NOAC E CORRECTED NOA E-MAILED Loading...
Nov 3, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 2, 2017 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Nov 2, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 30, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 19, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 19, 2017 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Oct 19, 2017 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Oct 19, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 15, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 13, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 13, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 13, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 18, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 14, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 14, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 14, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 19, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 23, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 23, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 3, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 9, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 8, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 7, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 7, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 12, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 12, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 12, 2015 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 12, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2015 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
Aug 6, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 4, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research and development in the field of therapeutic biochemicals, engineered cell therapies and immunotherapy; medical and scientific research and development for agents, preparations, products and technology in the field of dysregulated proteolytic activities; providing medical and scientific research information in the fields of biochemicals, engineered cell therapies, immunotherapy, oncology and dysregulated proteolytic activity; scientific investigations for medical purposes; medical research
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
PRO BODY

Classification

International Classes
042